HanchorBio partners with WuXi Biologics for development and manufacturing of next-gen bi- and multi-functional fusion programmes

Roivant to announce Q3 2026 financial results

AbbVie licenses PD-1/VEGF bispecific antibody RC148 from RemeGen in multi-billion dollar oncology deal

HUTCHMED reports positive Phase III results for sovleplenib in wAIHA

Physiomics secures follow-on UK contract for Phase 2 study support

Amgen's UPLIZNA receives US FDA approval

Physiomics secures new contract with Numab Therapeutics for preclinical antibody development

InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy

Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011

AstraZeneca to invest USD2bn in major Maryland manufacturing expansion

European Commission approves Celltrion's Remsima IV liquid formulation

TIRmed Pharma partners with Bachem to advance production of atopic dermatitis therapy

Fondazione Telethon reports positive opinion for Waskyra marketing authorisation in Europe

Vascarta and CUNY report positive preclinical results in glioblastoma treatment

CARsgen Therapeutics reports positive early clinical data for allogeneic CAR-T therapies CT0596 and CT1190B